Clinical response to everolimus in a patient with Hodgkin’s lymphoma harboring a TSC2 mutation
Crossref DOI link: https://doi.org/10.1038/bcj.2016.25
Published Online: 2016-05-13
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Perini, G F
Campregher, P V
Ross, J S
Ali, S
Hamerschlak, N
Santos, F P S
Text and Data Mining valid from 2016-05-13
Version of Record valid from 2016-05-13
Article History
First Online: 13 May 2016
Competing interests
: PVC, SA and JSR are employees of Foundation Medicine Inc.